Ronald Dorenbos

Ronald Dorenbos

International Harvard-trained Life Science Professional
 

Currently employed at Harvard Medical School

 

Previous: University Of Groningen

 

    Summary

    Highly accomplished and multi-lingual International Project Leader in Healthcare who worked with different companies and institutes throughout Europe and the US like Harvard, Genencor and Novo Nordisk. A record of achievements leading scientific projects promoting the practical application of Molecular Biology and Neuroscience in the advancement of disease study and health care delivery. A thorough understanding of the biotech and pharmaceutical industry and experienced in business development and project management. A versatile team player, mentor, and motivator to business professionals, scientists, and physicians supporting the advancement, development, and commercialization of life science-centered innovations as well as discovery of new cures for diseases precipitated by parasitic helminthes, poultry viruses and neurodegenerative diseases including Parkinson’s and motor neuron disease (ALS). Manager, educator, and public speaker. Author or co-author of 8 research papers as well as a book chapter. A featured scientific presenter at more than 15 meetings and conferences for respected organizations including the Society for Neuroscience, Association for Research in Vision and Ophthalmology, European Bacillus Secretion Group, the Dutch Government and more recently as a key contributor to biotech startups collaborating with leadership teams around business planning, provisionary patent application drafting, and market research. Project Leader at RXi Pharmaceuticals, a company founded in 2006 by Nobel prize winner Craig Mello. Leading a prohect that aims to develop RNAi-based therapeutics for ALS (Lou Gehrig's Disease). Senior Research Scientist at the Neurology Department headed by Dr. Robert Brown at UMass Medical School. Associate at Munevar & Associates, Inc., a life science technology development and commercialization solutions company. Formerly, as a Postdoc at Harvard Medical School, I studied dopamine-producing cells that play a role in conditions like Parkinson’s, schizophrenia, and addiction. I used techniques such as single-cell RT-PCR, immunocytochemistry and microarray hybridization. Identification of the biological clock in this cell was one of the results of my work. Furthermore, I am involved in studies of social behavior (such as aggression) in fruit flies. I look forward to leading more projects and to working together with enthusiastic people for future advancement of scientific research. Over 10 years experience in scientific research in: • Molecular biology • Microbiology • Neuroscience • Biotechnology Experience with: • Viruses • Bacteria • Nematodes • Fruit flies • Mice Worked in the UK, the Netherlands, Italy, and the US. PhD-thesis on thiol-disulfide oxidoreductases in Bacillus subtilis. Highly involved in a European project to use B. subtilis as ‘Cell Factory’ (minimizing the genome) with partners from France, Spain, Germany, Finland, Ireland and the UK. Specialties: Managing and leading research projects, teaching students, scientific reviewing and writing, using a variety of molecular biology techniques, single-cell RT-PCR, In Situ Hybridization, Patch Clamp, microarray hybridization, immunocytochemistry, (confocal) microscopy, Laser Capture Microdissection & Laser Pressure Catapulting. Knowledge of a variety of bioinformatics tools.

Experiences

Postdoc

At Harvard Medical School

 

University Of Groningen, Groningen

Thiol-disulfide oxidoreductases in Bacillus subtilis, University of Groningen

From 1998 to 2003
Pharmaceutical Biology - PhD in Molecular Biology. Thesis on disulfide-bond formation in Bacillus subtilis.
 

Skills

 
  • Biology
  • Biotechnology
  • Leader
  • Life sciences
  • Manager
  • Médical
  • Microbiology
  • Microsoft Project
  • Show all skills (11)

Centres d'intérêt

 
  • Business
  • science & music.